Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbamazepine in nonresponsive psychosis.

V M Neppe1

  • 1Department of Psychiatry, University of Washington, Seattle 98195.

The Journal of Clinical Psychiatry
|April 1, 1988
PubMed
Summary

Carbamazepine may benefit patients with nonresponsive psychosis, particularly those with aggression and agitation refractory to standard neuroleptics. Further research is needed to clarify its role and mechanism in treating psychosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysproccia: a necessary new term for impaired higher brain processing.

The Journal of neuropsychiatry and clinical neurosciences·2001
Same author

Buspirone in the treatment of tardive dyskinesia.

Journal of clinical psychopharmacology·1993
Same author

Capgras' syndrome of self.

The Journal of neuropsychiatry and clinical neurosciences·1992
Same author

Carbamazepine for atypical psychosis with episodic hostility.

The Journal of nervous and mental disease·1991
Same author

The use of carbamazepine to treat benzodiazepine withdrawal in a geriatric population.

Journal of geriatric psychiatry and neurology·1991
Same author

Carbamazepine for high-dose diazepam withdrawal in opiate users.

The Journal of nervous and mental disease·1991

Area of Science:

  • Psychiatry
  • Neuroscience

Background:

  • Nonresponsive psychosis presents a challenge, with heterogeneous patient subgroups.
  • Some patients remain symptomatic despite adequate neuroleptic treatment.

Purpose of the Study:

  • To explore the adjunctive use of carbamazepine in nonaffective, nonepileptic psychotics.
  • To identify target symptoms and features indicating carbamazepine's potential efficacy.

Main Methods:

  • Review of existing literature, including studies by Neppe and Klein.
  • Comparison of blind and nonblind studies on carbamazepine in psychosis.

Main Results:

  • Carbamazepine may be beneficial for patients with aggression, interpersonal difficulties, instability, and agitation refractory to neuroleptics.
  • The role of temporal-lobe symptomatology is unclear.
  • Carbamazepine's mechanism may involve an antikindling-like effect rather than direct antipsychotic action.

Conclusions:

  • Carbamazepine shows potential as an adjunctive treatment for specific subgroups of nonresponsive psychosis.
  • Further research is essential to elucidate its mechanism and optimal application.
  • Psychodynamic factors should also be considered in treatment approaches.

Related Experiment Videos